SFN was able to act at the epigenetic level, increasing the expression of Nrf2 and then enhancing antioxidant and anti-inflammatory capacity in an in vitro model of AD (N2a/APP cells) [75]. The gene discussed is SFN; the disease is Alzheimer disease.